MedTrace Logo

Early Shockwave Therapy for Post-RP ED

NCT03905057 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2019-04-08

No results posted yet for this study

Summary

This pilot study aims to explore the feasibility, safety and effectiveness of two different extracorporeal shock wave therapy (ESWT) protocols for patients receiving nerve-sparing radical prostatectomy (RP).

Conditions

  • Erectile Dysfunction Following Radical Prostatectomy

Interventions

DEVICE

Dornier Aries 2 (with active applicator)

Active ESWT: 5000 shockwaves per session. 2 ESWT sessions per week, 12 sessions in total.

DEVICE

Dornier Aries 2 (with sham applicator)

Sham ESWT - No shockwave administered

Sponsors & Collaborators

  • Hospital Universitari de Bellvitge

    collaborator OTHER

  • Dornier MedTech Systems

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-26
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03905057 on ClinicalTrials.gov